Prestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare Inc. (PBH) from its SEC filings: 2025 revenue $1.1 billion (-4% vs the year before), net margin 18%, free cash flow $246.4 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $1.1 billion |
| Revenue growth | -4% |
| Net income | $190.3 million |
| Net margin | 17.5% |
| Free cash flow | $246.4 million |
| Diluted EPS | $3.91 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +6% |
| Cash | $89.1 million |
| Long-term debt | $2.0 billion |
| Share count, 1 year | -4% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.